Reduction of Coronavirus Burden With Mass Azithromycin Distribution.
prospective_cohort · Level II
Where this comes from
- Record sourced from PubMed, PMID 32426812.
- Also identified by DOI 10.1093/cid/ciaa606 and PMC identifier 7314118.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
We evaluated the potential antiviral effects of azithromycin on the nasopharyngeal virome of Nigerien children who had received multiple rounds of mass drug administration. We found that the respiratory burden of non-severe acute respiratory syndrome coronaviruses was decreased with azithromycin distributions. Clinical Trials Registration. NCT02047981.
Medical subject headings
- Antiviral Agents
- Azithromycin
- Coronavirus Infections
- Mass Drug Administration
- Nasopharynx
- Viral Load